AAAAI Highlights

Asthma affects more than 25 million individuals in the United States, and remains a significant source of morbidity, mortality, and healthcare-related costs. Although many patients with asthma can achieve disease control with standard therapies, others have severe asthma that remains inadequately controlled despite adherence to conventional treatments, resulting in ongoing disease burden, poor health-related quality of life, and a decline in lung function. Researchers continue to study the safety and efficacy of novel agents for the treatment of asthma, as well as patient- and disease-related factors that can affect patient outcomes.

Read More ›

Subscribe to
Respiratory Practice Management

Stay up to date with respiratory news & updates by subscribing to receive the free RPM print publications or e‑Newsletter.

I'd like to recieve: